Close Menu

With cheap sequencing on the horizon, the genetics of genealogy will be in the hands of the consumers that acquire the information, writes blogger Blaine Bettinger at The Genetic Genealogist. Whether they will know what to do with this information is another issue, which begs the question, should people be encouraged to have their genomes sequenced without further studies that actually link this with phenotypic information?

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.